These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21881461)

  • 1. Six-year mortality rates of patients in methadone and buprenorphine maintenance therapy: results from a nationally representative cohort study.
    Soyka M; Träder A; Klotsche J; Backmund M; Bühringer G; Rehm J; Wittchen HU
    J Clin Psychopharmacol; 2011 Oct; 31(5):678-80. PubMed ID: 21881461
    [No Abstract]   [Full Text] [Related]  

  • 2. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients.
    Soyka M; Apelt SM; Lieb M; Wittchen HU
    J Clin Psychopharmacol; 2006 Dec; 26(6):657-60. PubMed ID: 17110826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment.
    Pinto H; Maskrey V; Swift L; Rumball D; Wagle A; Holland R
    J Subst Abuse Treat; 2010 Dec; 39(4):340-52. PubMed ID: 20817384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
    Curcio F; Franco T; Topa M; Baldassarre C;
    Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to opioid maintenance treatment reduces long-term mortality.
    Gibson A; Degenhardt L; Mattick RP; Ali R; White J; O'Brien S
    Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Buprenorphine or methadone for detoxification of young opioid addicts?].
    Ebner R; Schreiber W; Zierer C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study.
    Clausen T; Anchersen K; Waal H
    Drug Alcohol Depend; 2008 Apr; 94(1-3):151-7. PubMed ID: 18155364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study.
    Bukten A; Skurtveit S; Gossop M; Waal H; Stangeland P; Havnes I; Clausen T
    Addiction; 2012 Feb; 107(2):393-9. PubMed ID: 21883606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
    Winstock AR; Lintzeris N; Lea T
    Int J Drug Policy; 2011 Jan; 22(1):77-81. PubMed ID: 20956077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
    Maas J; Barton G; Maskrey V; Pinto H; Holland R
    Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blessing or problem child? Substitution therapy for opiate-addicted patients].
    Pallenbach E
    Pharm Unserer Zeit; 2002; 31(1):90-5. PubMed ID: 11852662
    [No Abstract]   [Full Text] [Related]  

  • 13. Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
    Stimmel B
    J Addict Dis; 2001; 20(4):1-5. PubMed ID: 11760922
    [No Abstract]   [Full Text] [Related]  

  • 14. Maintenance for opioid addiction with buprenorphine and methadone: "The only thing new in the world is the history you don't know".
    Stimmel B
    J Addict Dis; 2005; 24(3):1-6. PubMed ID: 16186079
    [No Abstract]   [Full Text] [Related]  

  • 15. Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine.
    Schaub M; Chtenguelov V; Subata E; Weiler G; Uchtenhagen A
    Int J Drug Policy; 2010 May; 21(3):229-33. PubMed ID: 19926271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abstinence orientation and treatment practice: an analysis of German settings providing opioid maintenance therapy.
    Trautmann S; Wittchen HU
    Subst Use Misuse; 2012 Jan; 47(1):22-30. PubMed ID: 22060728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
    Maremmani I; Pani PP; Pacini M; Perugi G
    J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first 38 methadone maintenance treatment patients in Stockholm: 15-year follow-up with a main focus on detoxification from methadone.
    Hiltunen AJ; Eklund C; Borg S
    Nord J Psychiatry; 2011 Apr; 65(2):106-11. PubMed ID: 20662685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample.
    Soyka M; Strehle J; Rehm J; Bühringer G; Wittchen HU
    Eur Addict Res; 2017; 23(2):97-105. PubMed ID: 28376505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a substance abuse program for opioid-dependent nonurban pregnant women improves outcome.
    Meyer M; Benvenuto A; Howard D; Johnston A; Plante D; Metayer J; Mandell T
    J Addict Med; 2012 Jun; 6(2):124-30. PubMed ID: 22517450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.